Atlas Trials

Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

Clinical trial NCT06966388 · RECRUITING

Trial details

NCT number
NCT06966388
Sponsor
Virginia Commonwealth University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2025-08-13
Primary completion
2027-11-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.